levetiracetam solution
tolmar inc. - levetiracetam (unii: 44yrr34555) (levetiracetam - unii:44yrr34555) - levetiracetam 100 mg in 1 ml
paliperidone palmitate kit
tolmar inc. - paliperidone palmitate (unii: r8p8usm8fr) (paliperidone - unii:838f01t721) -
eligard- leuprolide acetate injection, suspension, extended release
tolmar inc. - leuprolide acetate (unii: 37jns02e7v) (leuprolide - unii:efy6w0m8tg) - eligard® is indicated for the treatment of advanced prostate cancer. hypersensitivity eligard is contraindicated in patients with hypersensitivity to gnrh, gnrh agonist analogs or any of the components of eligard. anaphylactic reactions to synthetic gnrh or gnrh agonist analogs have been reported in the literature. risk summary based on findings in animal studies and mechanism of action, eligard may cause fetal harm when administered to a pregnant woman [see clinical pharmacology (12.1)] . there are no available data in pregnant women to inform the drug-associated risk. expected hormonal changes that occur with eligard treatment increase the risk for pregnancy loss. in animal developmental and reproductive studies, major fetal abnormalities were observed after administration of leuprolide acetate throughout gestation in rats. advise pregnant patients and females of reproductive potential of the potential risk to the fetus (see data) . animal data in animal developmental and reproductive studies, majo
eligard ® powder and solvent for solution for injection 22.5mg
dch auriga singapore - leuprorelin 20.87 mg eqv to leuprorelin acetate - injection, powder, lyophilized, for suspension,extended release - 22.5 mg - leuprorelin 20.87 mg eqv to leuprorelin acetate 22.5 mg
eligard ® powder and solvent for solution for injection 45mg
dch auriga singapore - leuprorelin 41.7 mg eqv leuprorelin acetate - injection, powder, lyophilized, for suspension,extended release - 45mg - leuprorelin 41.7 mg eqv leuprorelin acetate 45mg
eligard ® powder and solvent for solution for injection 7.5mg
dch auriga singapore - leuprorelin 6.96 mg eqv leuprorelin acetate - injection, powder, lyophilized, for suspension,extended release - 7.5 mg - leuprorelin 6.96 mg eqv leuprorelin acetate 7.5 mg
diclofenac sodium- diclofenac sodium gel
remedyrepack inc. - diclofenac sodium (unii: qtg126297q) (diclofenac - unii:144o8ql0l1) - diclofenac sodium 30 mg in 1 g - diclofenac sodium gel, 3% is indicated for the topical treatment of actinic keratoses (ak). sun avoidance is indicated during therapy. diclofenac sodium gel, 3% is contraindicated in patients with a known hypersensitivity to diclofenac, benzyl alcohol and/or polyethylene glycol monomethyl ether 350. diclofenac sodium gel, 3% is contraindicated in the following patients: - in the setting of coronary artery bypass graft (cabg) surgery.
diclofenac sodium gel
lake erie medical dba quality care products llc - diclofenac sodium (unii: qtg126297q) (diclofenac - unii:144o8ql0l1) - diclofenac sodium gel, 3% is indicated for the topical treatment of actinic keratoses (ak). sun avoidance is indicated during therapy. diclofenac sodium gel, 3% is contraindicated in patients with a known hypersensitivity to diclofenac, benzyl alcohol and/or polyethylene glycol monomethyl ether 350. diclofenac sodium gel, 3% is contraindicated in the following patients: - in the setting of coronary artery bypass graft (cabg) surgery.
eligard 7.5mg powder & solvent for solution for injection
dch auriga (malaysia) sdn. bhd. - leuproreline acetate -
eligard 22.5mg powder & solvent for solution for injection
dch auriga (malaysia) sdn. bhd. - leuproreline acetate -